Trial finds insulin nasal spray may slow age-related cognitive decline
The results of a clinical trial offer promising signs that daily doses of an insulin nasal spray could be used to slow age-related cognitive decline. The trial found the treatment to be effective in elderly subjects with and without type 2 diabetes. Source of Article